Vincent Koike, DO
Family Medicine · Everett, WANPI 1497843213
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AstraZeneca at 38.6% of the total. Reporting peaked in 2021 at $655 and has fallen 87.4% since, to $82 in 2025. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$998
- AbbVie$370
- Pfizer$279
- Boehringer Ingelheim$193
- Exact Sciences$186
- Lilly USA, LLC$169
- plus $390 from 11 others
What the payments were for
- Food & beverage$2,585100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 57 | $998 |
| AbbVie(2 entities) | 22 | $370 |
| Pfizer | 17 | $279 |
| Boehringer Ingelheim | 9 | $193 |
| Exact Sciences | 7 | $186 |
| Lilly USA, LLC | 11 | $169 |
| GSK | 5 | $86 |
| Biohaven Pharmaceuticals, Inc. | 3 | $52 |
| Eisai Inc. | 3 | $51 |
| Johnson & Johnson | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Bayer | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Medicomp Inc | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$2,585 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 11 | $4,917 |
| Oxycodone Hcl | 42 | $519 |
| Omeprazole | 20 | $308 |
| Pravastatin Sodium | 30 | $240 |
| Amlodipine Besylate | 29 | $236 |
| Atorvastatin Calcium | 13 | $231 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $223 |
| Baclofen | 14 | $206 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $196 |
| Levothyroxine Sodium | 14 | $174 |
| Metformin Hcl | 39 | $170 |
| Lisinopril | 29 | $139 |
| Buspirone Hcl | 12 | $121 |
| Metoprolol Succinate | 14 | $89 |
| Amoxicillin | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Everett
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
- Kent WalkerSumner$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.